These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 15208274)

  • 1. The transcription factor NRF2 protects against pulmonary fibrosis.
    Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
    FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance.
    Kikuchi N; Ishii Y; Morishima Y; Yageta Y; Haraguchi N; Itoh K; Yamamoto M; Hizawa N
    Respir Res; 2010 Mar; 11(1):31. PubMed ID: 20298567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
    Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
    Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.
    Madtes DK; Elston AL; Kaback LA; Clark JG
    Am J Respir Cell Mol Biol; 2001 May; 24(5):599-607. PubMed ID: 11350830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis.
    Manoury B; Nenan S; Leclerc O; Guenon I; Boichot E; Planquois JM; Bertrand CP; Lagente V
    Respir Res; 2005 Jan; 6(1):11. PubMed ID: 15663794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of nuclear factor erythroid 2-related factor 2 via extracellular signal-regulated kinase contributes to bleomycin-induced oxidative stress and fibrogenesis.
    Liu R; Chen H; Bai H; Zhang W; Wang X; Qin X; Zhang X; Li W; Liang X; Hai C
    Toxicol Lett; 2013 Jun; 220(1):15-25. PubMed ID: 23570914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
    Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
    J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of alpha-lipoic acid on bleomycin-induced pulmonary fibrosis in rats.
    Liu R; Ahmed KM; Nantajit D; Rosenthal FS; Hai CX; Li JJ
    Int J Mol Med; 2007 Jun; 19(6):865-73. PubMed ID: 17487418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kinetics and mechanism in bleomycin-induced murine pulmonary fibrosis model].
    Hu P; Gao ZC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Aug; 18(8):474-8. PubMed ID: 16887059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
    Gurujeyalakshmi G; Wang Y; Giri SN
    J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin.
    Oury TD; Thakker K; Menache M; Chang LY; Crapo JD; Day BJ
    Am J Respir Cell Mol Biol; 2001 Aug; 25(2):164-9. PubMed ID: 11509325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
    Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM
    J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of high mobility group box1 in pulmonary fibrosis.
    Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
    Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
    Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
    Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
    Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.
    Chitra P; Saiprasad G; Manikandan R; Sudhandiran G
    Toxicol Lett; 2013 May; 219(2):178-93. PubMed ID: 23523906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.